The President and CEO of Azbil Telstar, Ton Capella, is appointed President of the PharmaProcess Organizing Committee


 

The President and CEO of Azbil Telstar, Ton Capella will preside over the Organising Committee of PharmaProcess, international forum at the service of the pharmaceutical industry, which will be held from October 29th to 30th in Fira de Barcelona's Montjuïc Palacio de Congresos (Congress Hall), as agreed by Fira de Barcelona's Administrative Board.  
 
48-year old Capella, who graduated in industrial engineering from the Polytechnic University of Catalonia (UPC), is Executive President of Telstar, a multinational company founded in 1963 with headquarters in Terrassa, dedicated to design, manufacture and marketing of high-tech equipment for the industry linked to life and health sciences. In 2012, the Japanese business group Azbil took an equity participation in Telstar, which has five production plants in Spain, the United States, Estonia, France, the Netherlands, the United Kingdom and China and also has nine technological centres in 17 countries. 
 
The PharmaProcess Forum is fruit of the agreement between the sector's leading companies and associations and Fira de Barcelona to organise the European Union's first independent congress event about pharmaceutical processes. 
The first ever PharmaProcess will convene this industry's most important experts to reveal the sector's latest technical advances in a programme consisting of two plenary sessions and various conferences about the optimization of the process in order to improve the profitability of the production of the drug.
 
The clear vocation of the forum is to create a debate space, a premiere in Europe, which allows the exchange of know-how and expertise on organisational and technological innovation in pharmaceutical processes in order to achieve maximum optimisation of resources.